八十多岁人中心房动的冷热气球移除:基于倾向得分的分析,使用更年轻的队列
Federico Cecchini1,2, Giacomo Mugnai2,3, Shuichiro Kazawa2
1Electrophysiology Unit, Maria Cecilia Hospital, Cotignola, RA, Italy.
Journal of cardiovascular medicine (Hagerstown, Md.)
|June 7, 2023
概括
结冷气球切除 (CB-A) 用于肺静脉隔离 (PVI) 是安全有效的八十岁的患者,与年轻的患者相比. 这项研究证实了CB-A.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗器械 医疗器械
背景情况:
- 冰冷气球移除 (CB-A) 是一种在有症状的心房动中用于肺静脉隔离 (PVI) 的公认方法.
- 关于八十岁以上 (≥80岁) 患者的CB-A结果的数据有限.
- 在这个年龄段对CB-A的先前研究主要是单中心的经验.
研究的目的:
- 为了比较指数CB-A对PVI的有效性和安全性,八十多岁的患者与年轻的患者相比.
- 评估接受PVI的老年患者CB-A的结局和并发症率.
主要方法:
- 对97名连续八十岁的八十岁患者进行回顾性分析,这些患者接受了第二代CB-A的PVI.
- 倾向性得分匹配被用来创建一个由70名年轻患者组成的对照组.
- 两组之间的成功率,并发症率和心律失常复发的预测因素的比较.
主要成果:
- 经过23个月的中位随访后,八十多岁的总体成功率为60.0%,年轻的对照组为71.4% (P=0.17).
- 神经发生在8.6%的八十岁患者和7.1%的年轻患者中 (P=0.51).
- 严重的并发症很少见,在老年人群中有一例尿液,在对照组中有一例大腿动脉伪动脉瘤.
结论:
- 在适当选择的八十岁患者中,冷热气球除PVI是可行的,安全的和有效的.
- 八十多岁患者的结局和并发症率与年轻患者队列中的结果相似.
- 在空白期期间心律失常的复发和需要电动心脏转换预测晚期复发.
相关概念视频
01:25Dysrhythmias VI: Management of Dysrhythmias
19
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19
01:26Mitral Stenosis III: Medical Management
14
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14